February 2 RxAdvocate December, 2022 — Newsletter
FDA Approves new Hemophilia B Drug US Drug Supplies Tripledemic Annual Leadership Onsite...
Author: admin
February 2 RxAdvocate November, 2022 — Newsletter
Opiod Epidemic Lawsuits Overdose Reversal OTC New Discount Card Partnership...
February 2 RxAdvocate October, 2022 — Newsletter
Malaria Vaccine Botox Rival Revance Gets U.S. Approval COVID-19 Vaccine Boosters Organizational Announcement Team Community Involvement ...
February 2 RxAdvocate September, 2022 — Newsletter
Malaria Vaccine Botox Rival Revance Gets U.S. Approval COVID-19 Vaccine Boosters Organizational Announcement Team Community Involvement ...
February 2 RxAdvocate August, 2022 — Newsletter
Dobbs v. Jackson FDA Vitiligo Therapy Consolidated Appropriations Act ...
February 2 RxAdvocate July, 2022 — Newsletter
UV Safety Month Omnipod Coverage Sildenafil Recognized as Candidate for Alzheimer's RxConnection Team Involvement...
June 6 RxAdvocate June, 2022 — Newsletter
FDA Approves Alopecia Drug Cancer Study Results in 100% Patient Remission COVID-19 & Cardiovascular Health COVID-19 Vaccinations Authorized - Children 4 & Under RxConnection Organization Announcements...
June 6 RxAdvocate May, 2022 — Newsletter
CVD Prevention With Aspirin Kids Aged 4 & Under - COVID-19 Vaccines FDA Withdraws Ukoniq Approval...
May 5 RxAdvocate April, 2022 — Newsletter
Cervical Cancer Immunotherapy House Passes Bill Capping Insulin Prices FDA Approvals RxConnection Organizational Announcements...
March 3 RxAdvocate March, 2022 — Newsletter
- Purdue Pharma Comes to Opioid Settlement - USPSTF Lowers Bowel Prep Age Recommendation - Psychedelic Therapy - Additional COVID-19 Home Tests - RxConnection Organizational Announcements...